An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ
- PMID: 25409143
- PMCID: PMC4297557
- DOI: 10.1038/nature13887
An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ
Abstract
Obesity-linked insulin resistance is a major precursor to the development of type 2 diabetes. Previous work has shown that phosphorylation of PPARγ (peroxisome proliferator-activated receptor γ) at serine 273 by cyclin-dependent kinase 5 (Cdk5) stimulates diabetogenic gene expression in adipose tissues. Inhibition of this modification is a key therapeutic mechanism for anti-diabetic drugs that bind PPARγ, such as the thiazolidinediones and PPARγ partial agonists or non-agonists. For a better understanding of the importance of this obesity-linked PPARγ phosphorylation, we created mice that ablated Cdk5 specifically in adipose tissues. These mice have both a paradoxical increase in PPARγ phosphorylation at serine 273 and worsened insulin resistance. Unbiased proteomic studies show that extracellular signal-regulated kinase (ERK) kinases are activated in these knockout animals. Here we show that ERK directly phosphorylates serine 273 of PPARγ in a robust manner and that Cdk5 suppresses ERKs through direct action on a novel site in MAP kinase/ERK kinase (MEK). Importantly, pharmacological inhibition of MEK and ERK markedly improves insulin resistance in both obese wild-type and ob/ob mice, and also completely reverses the deleterious effects of the Cdk5 ablation. These data show that an ERK/Cdk5 axis controls PPARγ function and suggest that MEK/ERK inhibitors may hold promise for the treatment of type 2 diabetes.
Figures
![Extended Data 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4297557/bin/nihms630496f6.gif)
![Extended Data 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4297557/bin/nihms630496f7.gif)
![Extended Data 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4297557/bin/nihms630496f8.gif)
![Extended Data 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4297557/bin/nihms630496f9.gif)
![Extended Data 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4297557/bin/nihms630496f10.gif)
![Extended Data 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4297557/bin/nihms630496f11.gif)
![Extended Data 7](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4297557/bin/nihms630496f12.gif)
![Extended Data 8](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4297557/bin/nihms630496f13.gif)
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4297557/bin/nihms630496f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4297557/bin/nihms630496f2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4297557/bin/nihms630496f3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4297557/bin/nihms630496f4.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4297557/bin/nihms630496f5.gif)
Similar articles
-
Sonic hedgehog signaling instigates high-fat diet-induced insulin resistance by targeting PPARγ stability.J Biol Chem. 2019 Mar 1;294(9):3284-3293. doi: 10.1074/jbc.RA118.004411. Epub 2018 Dec 20. J Biol Chem. 2019. PMID: 30573683 Free PMC article.
-
A novel non-agonist peroxisome proliferator-activated receptor γ (PPARγ) ligand UHC1 blocks PPARγ phosphorylation by cyclin-dependent kinase 5 (CDK5) and improves insulin sensitivity.J Biol Chem. 2014 Sep 19;289(38):26618-26629. doi: 10.1074/jbc.M114.566794. Epub 2014 Aug 6. J Biol Chem. 2014. PMID: 25100724 Free PMC article.
-
Potent Anti-Diabetic Actions of a Novel Non-Agonist PPARγ Ligand that Blocks Cdk5-Mediated Phosphorylation.2011 Jul 5 [updated 2013 Mar 7]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–. 2011 Jul 5 [updated 2013 Mar 7]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–. PMID: 23762958 Free Books & Documents. Review.
-
Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγ.Biochim Biophys Acta. 2012 Jul;1822(7):1090-5. doi: 10.1016/j.bbadis.2012.03.014. Epub 2012 Apr 4. Biochim Biophys Acta. 2012. PMID: 22504298 Free PMC article. Review.
-
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.Nature. 2010 Jul 22;466(7305):451-6. doi: 10.1038/nature09291. Nature. 2010. PMID: 20651683 Free PMC article.
Cited by
-
Sulfonylureas exert antidiabetic action on adipocytes by inhibition of PPARγ serine 273 phosphorylation.Mol Metab. 2024 Jul;85:101956. doi: 10.1016/j.molmet.2024.101956. Epub 2024 May 10. Mol Metab. 2024. PMID: 38735390 Free PMC article.
-
Recent advances of myotubularin-related (MTMR) protein family in cardiovascular diseases.Front Cardiovasc Med. 2024 Mar 11;11:1364604. doi: 10.3389/fcvm.2024.1364604. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38529329 Free PMC article. Review.
-
Large-scale comparison of machine learning methods for profiling prediction of kinase inhibitors.J Cheminform. 2024 Jan 30;16(1):13. doi: 10.1186/s13321-023-00799-5. J Cheminform. 2024. PMID: 38291477 Free PMC article.
-
Sphingolipids in mitochondria-from function to disease.Front Cell Dev Biol. 2023 Nov 21;11:1302472. doi: 10.3389/fcell.2023.1302472. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38078003 Free PMC article. Review.
-
IL-27 increases energy storage in white adipocytes by enhancing glucose uptake and fatty acid esterification.Adipocyte. 2023 Dec;12(1):2276346. doi: 10.1080/21623945.2023.2276346. Epub 2023 Nov 10. Adipocyte. 2023. PMID: 37948192 Free PMC article.
References
-
- Yu JG, et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes. 2002;51:2968–2974. - PubMed
-
- Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell. 1994;79:1147–1156. - PubMed
-
- Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA. Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology. 1994;135:798–800. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous